Quick Answer
BIO-PATH HOLDINGS, INC. reported Operating Income Loss of -$11.99 million for the year ending 2024.
- BIO-PATH HOLDINGS, INC. showed an increase of +24.3% in Operating Income Loss from 2023 to 2024.
- This data is from BIO-PATH HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2012: -$787.8 thousand | Q3 2012: -$840.5 thousand | Q1 2013: -$655.9 thousand | Q2 2013: -$428.6 thousand | Q3 2013: -$1.39 million | Q4 2013: -$791.0 thousand | Q1 2014: -$510.2 thousand | Q2 2014: -$1.27 million | Q3 2014: -$1.15 million | Q4 2014: -$1.60 million | Q1 2015: -$1.38 million | Q2 2015: -$1.13 million | Q3 2015: -$1.51 million | Q4 2015: -$1.46 million | Q1 2016: -$1.87 million | Q2 2016: -$1.94 million | Q3 2016: -$2.99 million | Q4 2016: -$1.67 million | Q1 2017: -$2.00 million | Q2 2017: -$2.33 million | Q3 2017: -$2.48 million | Q1 2018: -$1.92 million | Q2 2018: -$1.68 million | Q3 2018: -$3.08 million | Q1 2019: -$1.52 million | Q2 2019: -$2.49 million | Q3 2019: -$2.27 million | Q1 2020: -$3.34 million | Q2 2020: -$2.04 million | Q3 2020: -$2.97 million | Q1 2021: -$2.45 million | Q2 2021: -$1.81 million | Q3 2021: -$2.07 million | Q1 2022: -$3.36 million | Q2 2022: -$3.01 million | Q3 2022: -$3.55 million | Q1 2023: -$5.29 million | Q2 2023: -$4.24 million | Q3 2023: -$3.28 million | Q1 2024: -$3.70 million | Q2 2024: -$3.04 million | Q3 2024: -$2.63 million | Q1 2025: -$3.24 million | Q2 2025: -$4.56 million | Q3 2025: -$488.0 thousand.
- Over the full 15 years of available data (2010 to 2024), BIO-PATH HOLDINGS, INC.'s Operating Income Loss has declined by 415.5%.
- Historical annual values: Fiscal year 2024: -$11.99 million | Fiscal year 2023: -$15.84 million | Fiscal year 2022: -$13.90 million | Fiscal year 2021: -$10.44 million | Fiscal year 2020: -$10.91 million | Fiscal year 2019: -$8.69 million | Fiscal year 2018: -$8.59 million | Fiscal year 2017: -$8.97 million | Fiscal year 2016: -$8.48 million | Fiscal year 2015: -$5.49 million | Fiscal year 2014: -$4.54 million | Fiscal year 2013: -$3.27 million | Fiscal year 2012: -$2.58 million | Fiscal year 2011: -$2.37 million | Fiscal year 2010: -$2.33 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: